You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 2, 2025

Drug Price Trends for NDC 33342-0308


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 33342-0308

Drug NameNDCPrice/Unit ($)UnitDate
RASAGILINE MESYLATE 0.5 MG TAB 33342-0308-07 1.06452 EACH 2025-03-19
RASAGILINE MESYLATE 0.5 MG TAB 33342-0308-07 1.05300 EACH 2025-02-19
RASAGILINE MESYLATE 0.5 MG TAB 33342-0308-07 1.06467 EACH 2025-01-22
RASAGILINE MESYLATE 0.5 MG TAB 33342-0308-07 1.03260 EACH 2025-01-01
>Drug Name>NDC>Price/Unit ($)>Unit>Date
Showing 1 to 4 of 4 entries

Best Wholesale Price for NDC 33342-0308

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
No data available in table
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 0 to 0 of 0 entries

Market Analysis and Price Projections for the Drug NDC: 33342-0308

Understanding the National Drug Code (NDC)

To begin analyzing the market and pricing for a drug identified by the NDC 33342-0308, it is crucial to understand what the NDC represents. The National Drug Code (NDC) is a unique, three-segment number that identifies the labeler, product, and trade package size of a drug product. This code is essential for tracking and managing drug products in the pharmaceutical industry[1][5].

Identifying the Drug Product

The NDC 33342-0308 can be broken down into three segments:

  • Labeler Code: The first segment (33342) identifies the firm that manufactures, repackages, or relabels the drug.
  • Product Code: The second segment (0308) identifies the specific strength, dosage form, and formulation of the drug.
  • Package Code: The third segment identifies the package size and type.

Market Demand Analysis

Patient Population and Disease Prevalence

To project prices and market trends, it is essential to understand the demand for the drug. This involves analyzing the patient population and the prevalence of the condition the drug treats. For example, if the drug treats a chronic condition with a growing patient population, demand is likely to increase[2].

Competitive Landscape

The competitive landscape plays a significant role in determining the market position and pricing of the drug. If there are few competitors in the same therapeutic class, the drug may maintain a strong market position. However, if there is intense competition, especially from generic drugs or biosimilars, the pricing strategy may need to be adjusted to remain competitive[3].

Pricing Analysis

Historical Pricing Trends

Analyzing historical pricing data is crucial for understanding how the price of the drug has evolved over time. This includes looking at past trends, such as stable pricing or slight increases due to inflation. For instance, if historical data shows stable pricing with a slight increase, this trend may continue unless external factors intervene[2].

Competitor Pricing

Comparing the pricing of similar drugs in the market helps in determining a competitive pricing strategy. If similar drugs are priced within a narrow range, it suggests that the market is competitive, and pricing needs to be aligned with industry standards[2].

Forecasting Models

Regression Analysis

Using historical data, regression models can be built to predict future prices based on past trends and market conditions. This method helps in identifying the relationship between the drug's price and various market factors such as demand, competition, and economic conditions[2].

Time Series Analysis

Time series analysis involves identifying patterns and cycles in historical data to forecast future prices. This method can reveal seasonal patterns or other periodic changes in pricing that need to be considered in price projections[2].

External Factors

Economic Conditions

Economic conditions such as inflation rates and healthcare spending trends can significantly influence drug pricing. For example, if inflation is rising, drug prices may also increase to keep pace with the cost of living[2].

Policy Changes

Policy changes, such as changes in Medicare or Medicaid reimbursement rates, can impact the pricing of drugs. Staying updated with FDA regulations and other policy changes is essential for maintaining market position and compliance[2][4].

Scenario Analysis

Best-Case Scenario

In a best-case scenario, the drug faces high demand and limited competition, allowing for optimal pricing. This scenario assumes favorable market conditions and strong market positioning[2].

Worst-Case Scenario

In a worst-case scenario, the drug faces intense competition or regulatory challenges, leading to lower prices or reduced market share. This scenario helps in preparing for adverse market conditions[2].

Base-Case Scenario

The base-case scenario projects prices based on current market conditions and trends. This is often the most realistic scenario and serves as a benchmark for other projections[2].

Example: Analyzing NDC 33342-0308

Assuming the NDC 33342-0308 corresponds to a specific prescription drug:

  • Market Demand: If the drug treats a chronic condition with a growing patient population, demand is likely to increase.
  • Competitive Landscape: If there are few competitors in the same therapeutic class, the drug may maintain a strong market position.
  • Pricing Analysis: Historical data might show stable pricing over the past few years, but with a slight increase due to inflation.
  • Forecasting Models: Using regression analysis, the forecasted price for the next year might show a modest increase of 2-3% due to inflation and stable demand.

Key Takeaways

  • Market Analysis: Understanding the competitive landscape, market trends, and patient population is crucial for accurate price projections.
  • Pricing Strategies: Historical pricing, competitor pricing, and regulatory environment play significant roles in determining the drug's price.
  • Forecasting Models: Using regression and time series analysis can help in predicting future prices based on past data.
  • Regulatory Compliance: Staying updated with FDA regulations and Medicaid/Medicare policies is essential for maintaining market position and compliance[2].

Impact of External Factors

  • 340B Drug Pricing Program: Programs like the 340B Drug Pricing Program, which provide discounts to eligible hospitals, can impact the overall revenue and pricing strategy of drug companies. However, these discounts represent a small share of drug company revenues[4].
  • Patent Expirations: The looming patent expiration of high-revenue products can drive interest in mergers and acquisitions and impact the pricing and market position of drugs[3].

Future Outlook

The life sciences industry is poised for significant transformation driven by digital advancements and scientific innovations. Advances in genomics, biomarkers, and personalized medicine are expected to improve treatment efficacy and reduce side effects. The integration of technologies like AI and increased use of data will boost operational efficiencies and drive breakthrough innovations[3].

FAQs

Q: What does the National Drug Code (NDC) represent? A: The NDC is a unique, three-segment number that identifies the labeler, product, and trade package size of a drug product.

Q: How is the NDC used in market analysis? A: The NDC is used to track and manage drug products, analyze market trends, and project prices based on historical data and market conditions.

Q: What factors influence the pricing of drugs? A: Factors such as historical pricing trends, competitor pricing, economic conditions, and policy changes influence the pricing of drugs.

Q: How do forecasting models help in price projections? A: Forecasting models like regression analysis and time series analysis help predict future prices based on past trends and market conditions.

Q: What is the impact of the 340B Drug Pricing Program on drug companies? A: The 340B Drug Pricing Program provides discounts to eligible hospitals, which represents a small share of drug company revenues but can impact their pricing strategy and overall revenue.

Sources

  1. FDA: National Drug Code Database Background Information.
  2. DrugPatentWatch: Latest drug prices and trends for NDC 33342-0451.
  3. Deloitte Insights: 2025 life sciences outlook.
  4. American Hospital Association: The 340B Drug Pricing Program.
  5. FDA: National Drug Code Directory.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.